COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Remote ischemic conditioning (RIC) and intravenous exenatide administered immediately before
primary angioplasty have been found to limit infarct size in patients with STEMI (ST segment
elevation myocardial infarction), but the reduction is limited. This study investigates
whether a combination therapy including both therapies is more effective.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute